| Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). (NCT07611513) | Sinovac Biotech Co., Ltd | 2026-05-01 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months (NCT07505810) | Sinovac Biotech Co., Ltd | 2026-03-25 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months (NCT07505836) | Sinovac Biotech Co., Ltd | 2026-03-22 |
| Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months (NCT07505823) | Sinovac Biotech Co., Ltd | 2026-03-22 |
| Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine (NCT07418229) | Sinovac Biotech Co., Ltd | 2026-03-09 |
| Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine (NCT07416110) | Sinovac Biotech Co., Ltd | 2026-03-04 |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen (NCT07055295) | Sinovac Biotech Co., Ltd | 2026-03-01 |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen (NCT07055893) | Sinovac Biotech Co., Ltd | 2026-03-01 |
| Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine (NCT07400003) | Sinovac Biotech Co., Ltd | 2026-01-06 |
| Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine (NCT07457060) | Sinovac Biotech Co., Ltd | 2025-11-27 |
| Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women (NCT07211152) | Sinovac Biotech Co., Ltd | 2025-10-13 |
| Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations (NCT07354269) | Sinovac Biotech Co., Ltd | 2025-09-26 |
| Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) (NCT07055880) | Sinovac Biotech Co., Ltd | 2025-07-28 |
| Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). (NCT06754384) | Sinovac Biotech Co., Ltd | 2025-01-15 |
| Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) (NCT06734832) | Sinovac Biotech Co., Ltd | 2024-12-13 |
| Booster Dose of sIPV Co-administered With MMR and HepA-I. (NCT06442449) | Sinovac Biotech Co., Ltd | 2024-08-08 |
| Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia (NCT06251219) | Sinovac Biotech Co., Ltd | 2024-02-01 |
| The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students (NCT06208683) | Sinovac Biotech Co., Ltd | 2023-11-04 |
| Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old (NCT06058416) | Sinovac Biotech Co., Ltd | 2023-10-24 |
| Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial (NCT06063057) | Sinovac Biotech Co., Ltd | 2023-09-20 |
| A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months (NCT06049927) | Sinovac Biotech Co., Ltd | 2023-09-16 |
| Immunogenicity of After Primary Immunization and Booster Immunization of sIPV (NCT06058429) | Sinovac Biotech Co., Ltd | 2023-08-16 |
| A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine (NCT05850364) | Sinovac Biotech Co., Ltd | 2023-05-22 |
| Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine (NCT05731115) | Sinovac Biotech Co., Ltd | 2023-02-27 |
| A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia (NCT05637229) | Sinovac Biotech Co., Ltd | 2022-11-28 |
| Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated (NCT05512494) | Sinovac Biotech Co., Ltd | 2022-11-27 |
| Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine (NCT05477693) | Sinovac Biotech Co., Ltd | 2022-10-25 |
| A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months (NCT05245552) | Sinovac Biotech Co., Ltd | 2022-08-08 |
| An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) (NCT05397587) | Sinovac Biotech Co., Ltd | 2022-07-30 |
| Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (NCT05431725) | Sinovac Biotech Co., Ltd | 2022-07-18 |
| A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population (NCT07071701) | Sinovac Biotech Co., Ltd | 2022-07-02 |
| A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants (NCT05432141) | Sinovac Biotech Co., Ltd | 2022-06-13 |
| Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai (NCT05166044) | Sinovac Biotech Co., Ltd | 2022-01-04 |
| Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19 (NCT05079217) | Sinovac Biotech Co., Ltd | 2021-12-17 |
| Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine (NCT05471531) | Sinovac Biotech Co., Ltd | 2021-11-13 |
| Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) (NCT05107557) | Sinovac Biotech Co., Ltd | 2021-11-05 |
| A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine (NCT05499351) | Sinovac Biotech Co., Ltd | 2021-10-15 |
| A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old (NCT04997239) | Sinovac Biotech Co., Ltd | 2021-10-10 |
| A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine (NCT04989465) | Sinovac Biotech Co., Ltd | 2021-09-10 |
| An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses (NCT04989231) | Sinovac Biotech Co., Ltd | 2021-09-09 |
| Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried (NCT07357545) | Sinovac Biotech Co., Ltd | 2021-08-27 |
| Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants (NCT05386810) | Sinovac Biotech Co., Ltd | 2020-11-05 |
| Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine (NCT04386707) | Sinovac Biotech Co., Ltd | 2020-05-11 |
| Clinical Trial for Batch Consistency of EV71 Vaccine (NCT07026500) | Sinovac Biotech Co., Ltd | 2019-09-19 |
| Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines (NCT04111432) | Sinovac Biotech Co., Ltd | 2019-07-26 |
| Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization (NCT04618783) | Sinovac Biotech Co., Ltd | 2019-07-20 |
| Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) (NCT04075201) | Sinovac Biotech Co., Ltd | 2019-07-07 |
| Efficacy Trial of a Commercial EV71 Vaccine (NCT03903926) | Sinovac Biotech Co., Ltd | 2019-03-26 |
| Immunogenicity and Safety of Two Different Commercial EV71 Vaccines (NCT03873740) | Sinovac Biotech Co., Ltd | 2018-11-06 |
| A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants (NCT03822767) | Sinovac Biotech Co., Ltd | 2018-06-12 |
| A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants (NCT03822754) | Sinovac Biotech Co., Ltd | 2018-06-06 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml) (NCT03859141) | Sinovac Biotech Co., Ltd | 2018-02-06 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml) (NCT03853993) | Sinovac Biotech Co., Ltd | 2018-01-23 |